Evidence map›Paper›PMID 33233650›Full record

ReviewMolecules (Basel, Switzerland)2020

Mitocanic Di- and Triterpenoid Rhodamine B Conjugates.

Sophie Hoenke, Immo Serbian, Hans-Peter Deigner, René Csuk

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Targeting Energy Metabolism in Cancer Treatment.International journal of molecular sciences · 2022
    Review
  11. Madecassic Acid-A New Scaffold for Highly Cytotoxic Agents.International journal of molecular sciences · 2022
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Cytotoxic Potential of a-Azepano- and 3-Amino-3,4-SeCo-Triterpenoids.International journal of molecular sciences · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Sophie HoenkeOrganic Chemistry, Martin-Luther University Halle-Wittenberg, Kurt-Mothes Street 2, D-06120 Halle, Germany.
Immo SerbianOrganic Chemistry, Martin-Luther University Halle-Wittenberg, Kurt-Mothes Street 2, D-06120 Halle, Germany.ORCID 0000-0002-6527-6820
Hans-Peter DeignerMedical and Life Science Faculty, Institute of Precision Medicine, Furtwangen University, Jakob-Kienzle-Street 17, D-78054 Villigen-Schwenningen, Germany.ORCID 0000-0002-7745-0152
René CsukOrganic Chemistry, Martin-Luther University Halle-Wittenberg, Kurt-Mothes Street 2, D-06120 Halle, Germany.ORCID 0000-0001-7911-290X
Martin Luther University Halle-Wittenberg · DEFurtwangen University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The combination of the "correct" triterpenoid, the "correct" spacer and rhodamine B (

Indexed as

AnimalsAntineoplastic AgentsCell Line, TumorCell SurvivalChemistry Techniques, SyntheticHumansInhibitory Concentration 50MiceMolecular StructureRhodaminesStructure-Activity RelationshipTriterpenesAntineoplastic Agentsrhodamine BRhodaminesTriterpenesbetulinic acidcytotoxicitymaslinic acidoleanolic acidrhodamine Btormentic acidtriterpenoic acid

Identifiers

PMID33233650
PMCPMC7699795
OpenAlexW3102005841

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.